Search Results 811-820 of 14729 for anti-TNF drugs
Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of receiving it. This medicine is available ...
The purpose of this study is to evaluate the safety, tolerability, drug/body interactions, and preliminary activity of LAM-002A for the treatment of patients ...
Research has shown us that obesity increases likelihood of nonresponse to treatment with tumor necrosis factor α (TNFα) inhibitors, a staple in the treatment of ...
DEAR MAYO CLINIC: I've heard I should avoid certain foods like grapefruit and broccoli, as well as alcoholic beverages, when taking certain medications.
Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...
Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent. Participating Mayo Clinic locations. Study statuses change often. Please contact ...
... medications for Crohn's disease therapy -Prior treatment failure or intolerance with at least one Anti Tumor Necrosis Factor-Alpha Therapy (anti-TNF α) agent.
Vasculitis — giant cell arteritis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and all other forms of vasculitis. Systemic autoimmune ...
... anti-HER2 based regimens. It belongs to the group of medicines, called antineoplastics. Neratinib interferes with the growth of cancer cells, which are ...
By condition, treatment or drug name ... The doses of both drugs received will depend on when the patient is enrolled on to the study. ... an anti-CD38 monoclonal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.